ChemoRadiation And Tislelizumab for Esophageal/EGJ Cancer

Clinical trial NCT05245760 · WITHDRAWN

Trial details

NCT number: NCT05245760
Sponsor: Zhonglin Hao
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Cancer Esophagogastric Junction Cancer

Start date: 2022-04-01
Primary completion: 2023-03-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.